VISTAGEN THERAPEUTICS INC (VTGN:NASDAQ)
$0.2361 -0.0101 (-4.1024%)
Analysed VISTAGEN THERAPEUTICS INC (VTGN:NASDAQ) News Sources
Vistagen Achieves Minimum ICH Safety Exposure Recommendations Across Clinical Program for Fasedienol for the Acute Treatment of Social Anxiety Disorder
09-06-2026
yahoo.com
Vistagen Appoints Douglas J. Williamson to its Board of Directors
31-07-2026
yahoo.com
SRX Global Provides Shareholders with Update on Liquidation of Two Portfolio Investments and Adds an Investment in Onconetix (Nasdaq: ONCO)
24-09-2026
yahoo.com
SRX Global Acquires Stake in Vistagen Therapeutics (NASDAQ: VTGN)
04-08-2026
yahoo.com
SRX Global Acquires Stake in Vistagen Therapeutics
04-08-2026
advfn.com
Vistagen to Present at Psych Congress 2026
10-09-2026
yahoo.com
Vistagen Announces Preliminary Positive Data from Open-Label Extension Portion of PALISADE-4 Phase 3 Study of Fasedienol for the Acute Treatment of Social Anxiety Disorder
22-09-2026
yahoo.com
Vistagen Reports Positive Findings Supporting Fasedienol’s Potential in Very Severe Social Anxiety Disorder
24-09-2026
yahoo.com
Vistagen Presents Fasedienol Subgroup Data in Severe Social Anxiety Disorder
24-09-2026
advfn.com
2 Falling Stocks Call Traders Are Targeting Today
25-09-2026
yahoo.com
What is the current price of VISTAGEN THERAPEUTICS INC (VTGN:NASDAQ)?
The current price of VISTAGEN THERAPEUTICS INC (VTGN:NASDAQ) is $0.2361.
VISTAGEN THERAPEUTICS INC (VTGN:NASDAQ) absolute price change since previous trading day?
The absolute price change of VISTAGEN THERAPEUTICS INC (VTGN:NASDAQ) since the previous trading day is $-0.0101.
VISTAGEN THERAPEUTICS INC (VTGN:NASDAQ) percentage price change since previous trading day?
The percentage price change of VISTAGEN THERAPEUTICS INC (VTGN:NASDAQ) since the previous trading day is -4.1024%.
What is the most recent average sentiment score for VISTAGEN THERAPEUTICS INC (VTGN:NASDAQ)?
The most recent average sentiment score for VISTAGEN THERAPEUTICS INC (VTGN:NASDAQ) is 73 out of 100.
What is the most recent average sentiment for VISTAGEN THERAPEUTICS INC (VTGN:NASDAQ)?
The most recent sentiment for VISTAGEN THERAPEUTICS INC (VTGN:NASDAQ) is .
SEC-8K** Filing Available For VISTAGEN THERAPEUTICS INC (VTGN:NASDAQ)
** material developments that could impact a company's financial condition or stock price.
Author: MattELab
MattELab is the founder and lead developer of SentientMerchant. With a Computer Science and Quantitative Finance background from a T10 university, he brings over 6 years of expertise in NLP, programmatic SEO, and full-stack development to build highly scalable AI and FinTech solutions.